New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Telehealth considerably improved disparities in postpartum visit attendance for Black patients

Telehealth considerably improved disparities in postpartum visit attendance for Black patients

by Christine Weeks,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainMore than half of pregnancy-related deaths occur in the postpartum period, so when the COVID-19 pandemic caused post
OB & GYN April 19,2024
Telehealth considerably improved disparities in postpartum visit attendance for Black patients

Telehealth considerably improved disparities in postpartum visit attendance for Black patients

by Christine Weeks,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainMore than half of pregnancy-related deaths occur in the postpartum period, so when the COVID-19 pandemic caused post
OB & GYN April 19,2024
Discontinuing TNFi before gestational week 20 is feasible

Discontinuing TNFi before gestational week 20 is feasible

(HealthDay)—Discontinuing tumor necrosis factor inhibitors (TNFi) before gestational week 20 in women with well-controlled rheumatoid arthritis (RA) or juvenile idiopathic arthritis (JIA) is not assoc
OB & GYN April 19,2024
Discontinuing TNFi before gestational week 20 is feasible

Discontinuing TNFi before gestational week 20 is feasible

(HealthDay)—Discontinuing tumor necrosis factor inhibitors (TNFi) before gestational week 20 in women with well-controlled rheumatoid arthritis (RA) or juvenile idiopathic arthritis (JIA) is not assoc
OB & GYN April 19,2024
COVID-19 rates may be lower than thought for pregnant women

COVID-19 rates may be lower than thought for pregnant women

(HealthDay)—A new study suggests the rate of COVID-19 among pregnant women without symptoms is much lower than previously reported.Fewer than 3% ofasymptomatic womenadmitted to three Yale
OB & GYN April 19,2024
COVID-19 rates may be lower than thought for pregnant women

COVID-19 rates may be lower than thought for pregnant women

(HealthDay)—A new study suggests the rate of COVID-19 among pregnant women without symptoms is much lower than previously reported.Fewer than 3% ofasymptomatic womenadmitted to three Yale
OB & GYN April 19,2024
Long or short menstrual cycles linked to higher risk of cardiovascular disease

Long or short menstrual cycles linked to higher risk of cardiovascular disease

by American Heart AssociationCredit: Pixabay/CC0 Public DomainA study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher r
OB & GYN April 19,2024
Long or short menstrual cycles linked to higher risk of cardiovascular disease

Long or short menstrual cycles linked to higher risk of cardiovascular disease

by American Heart AssociationCredit: Pixabay/CC0 Public DomainA study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher r
OB & GYN April 19,2024
Blood tests for Alzheimer's: Why new studies are encouraging

Blood tests for Alzheimer's: Why new studies are encouraging

by Todd Golde And Steven Dekosky,The ConversationCredit: AI-generated imageMany people who have problems with their memory, especially if they are elderly, worry that they have Alzheimer's d
Neurology April 18,2024
Blood tests for Alzheimer's: Why new studies are encouraging

Blood tests for Alzheimer's: Why new studies are encouraging

by Todd Golde And Steven Dekosky,The ConversationCredit: AI-generated imageMany people who have problems with their memory, especially if they are elderly, worry that they have Alzheimer's d
Neurology April 18,2024
Early signs of Alzheimer's: Most older adults see the value of screening but haven't been tested

Early signs of Alzheimer's: Most older adults see the value of screening but haven't been tested

by University of MichiganFamiliarity with, and experience with, cognitive testing and Alzheimer's biomarker testing among adults age 65-80. Credit: University of MichiganSome 80% of older adu
Neurology April 18,2024
Early signs of Alzheimer's: Most older adults see the value of screening but haven't been tested

Early signs of Alzheimer's: Most older adults see the value of screening but haven't been tested

by University of MichiganFamiliarity with, and experience with, cognitive testing and Alzheimer's biomarker testing among adults age 65-80. Credit: University of MichiganSome 80% of older adu
Neurology April 18,2024
Alzheimer's study delves into degraded brain connections

Alzheimer's study delves into degraded brain connections

by University of Texas at DallasAs part of the study, researchers useddiffusion-tensor imaging to determine the integrity of white matter connections in the brain. Credit: University
Neurology April 18,2024
Alzheimer's study delves into degraded brain connections

Alzheimer's study delves into degraded brain connections

by University of Texas at DallasAs part of the study, researchers useddiffusion-tensor imaging to determine the integrity of white matter connections in the brain. Credit: University
Neurology April 18,2024
Early diagnosis of Alzheimer's: Ultra-long protein fibrils give clues on dementia risk

Early diagnosis of Alzheimer's: Ultra-long protein fibrils give clues on dementia risk

by Swiss Federal Laboratories for Materials Science and TechnologyAtomic force microscopy: Peter Nirmalraj investigates Alzheimer's disease at the nanometer scale. Credit: EmpaThe early detec
Neurology April 18,2024
Early diagnosis of Alzheimer's: Ultra-long protein fibrils give clues on dementia risk

Early diagnosis of Alzheimer's: Ultra-long protein fibrils give clues on dementia risk

by Swiss Federal Laboratories for Materials Science and TechnologyAtomic force microscopy: Peter Nirmalraj investigates Alzheimer's disease at the nanometer scale. Credit: EmpaThe early detec
Neurology April 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com